Stock Earnings

Question 1

What are Heron Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Heron Therapeutics Inc has a total asset of $233, Net loss of $-13

Question 2

What are the key financial ratios for HRTX?

Accepted Answer

Heron Therapeutics Inc's Current ratio is 0.87, has a Net margin is -9.02, sales per share of $0.94.

Question 3

How is Heron Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Heron Therapeutics Inc largest revenue segment is Therapeutic Innovations, at a revenue of 144,285,000 in the most earnings release.For geography, United States is the primary market for Heron Therapeutics Inc, at a revenue of 144,285,000.

Question 4

Is Heron Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Heron Therapeutics Inc has a net loss of $-13

Question 5

Does Heron Therapeutics Inc have any liabilities?

Accepted Answer

yes, Heron Therapeutics Inc has liability of 266

Question 6

How many outstanding shares for Heron Therapeutics Inc?

Accepted Answer

Heron Therapeutics Inc has a total outstanding shares of 152.12

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	155	144	127	107	86	88
Revenue Growth (YoY)	13%	13%	19%	24%	-2%	-40%
Cost of Revenue	40	38	65	54	46	36
Gross Profit	114	105	61	52	40	52
Selling, General & Admin	101	100	116	120	127	106
Research & Development	11	16	55	107	130	174
Operating Expenses	113	117	172	227	258	280
Other Non Operating Income (Expenses)	-3	0	0	-6	0	0
Pretax Income	-13	-13	-110	-182	-220	-227
Income Tax Expense	--	--	--	--	--	--
Net Income	-13	-13	-110	-182	-220	-227
Net Income Growth	-52%	-88%	-40%	-17%	-3%	11%
Shares Outstanding (Diluted)	170.34	152.44	138.13	108.9	98.5	90.8
Shares Change (YoY)	11%	10%	27%	11%	8%	11%
EPS (Diluted)	-0.08	-0.08	-0.8	-1.67	-2.24	-2.5
EPS Growth	-56%	-89%	-52%	-25%	-10%	0%
Free Cash Flow	-31	-24	-60	-148	-206	-191
Free Cash Flow Per Share	-0.18	-0.15	-0.43	-1.35	-2.09	-2.1
Gross Margin	73.54%	72.91%	48.03%	48.59%	46.51%	59.09%
Operating Margin	0.64%	-7.63%	-86.61%	-162.61%	-252.32%	-259.09%
Profit Margin	-8.38%	-9.02%	-86.61%	-170.09%	-255.81%	-257.95%
Free Cash Flow Margin	-20%	-16.66%	-47.24%	-138.31%	-239.53%	-217.04%
EBITDA	3	-9	-108	-172	-214	-226
EBITDA Margin	1.93%	-6.25%	-85.03%	-160.74%	-248.83%	-256.81%
D&A For EBITDA	2	2	2	2	3	2
EBIT	1	-11	-110	-174	-217	-228
EBIT Margin	0.64%	-7.63%	-86.61%	-162.61%	-252.32%	-259.09%
Effective Tax Rate	--	--	--	--	--	--

Heron Therapeutics Inc (HRTX) Price

HRTX Stock Price Chart

HRTX Income

Follow-Up Questions